TransMedics Group Inc (TMDX)

Operating profit margin

		Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Operating income (ttm)	US$ in thousands	31,455	-803	-14,217	-28,727	-38,109	-15,318	-24,157	-31,437	-35,986	-42,167	-42,290	-39,428	-33,996	-26,881	-24,874	-26,384	-29,182	-31,814	-31,658	-29,603
Revenue (ttm)	US$ in thousands	401,090	358,759	296,919	241,623	191,824	151,077	119,133	93,459	71,752	51,439	39,089	30,262	28,221	29,942	25,162	25,639	24,069	24,183	26,458	23,604
Operating profit margin		7.84%	-0.22%	-4.79%	-11.89%	-19.87%	-10.14%	-20.28%	-33.64%	-50.15%	-81.97%	-108.19%	-130.29%	-120.46%	-89.78%	-98.86%	-102.91%	-121.24%	-131.56%	-119.65%	-125.42%

September 30, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $31,455K ÷ $401,090K
= 7.84%

TransMedics Group Inc's operating profit margin has displayed fluctuations over the periods indicated in the table. The operating profit margin has shown improvement from negative figures in earlier periods to positive percentages in more recent quarters. However, the margin remains relatively low, indicating that the company's operating expenses are significant compared to its revenue generation. Management should continue to focus on cost control and efficiency to sustain and further enhance the operating profit margin in the future.